文献速递慢阻肺

COPD临床控制作为未来急性加重预测因子:SPARK研究人群中的概念验证

COPD clinical control as a predictor of future exacerbations: concept validation in the SPARK study population.
PubMed 文献 · Thorax · 2020-02-10

在SPARK研究人群中验证COPD临床控制概念的前瞻性价值。控制状态基于COPD稳定性和影响评估,第1-12周低影响且稳定者定义为控制,随访52周观察急性加重。2044例患者中80%为非控制,控制组中重度急性加重率显著更低(率比0.56,95%CI 0.48-0.65,p<0.0001),首次中重度急性加重时间显著延迟。

要点

  • COPD临床控制状态与未来急性加重风险相关。
  • 控制组中重度急性加重率显著低于非控制组(率比0.56)。
  • 控制组首次中重度急性加重时间显著延迟。

核心结论

  • COPD临床控制状态与未来急性加重风险存在关联。

研究设计与样本

  • 在SPARK研究人群中验证COPD控制概念的前瞻性价值,共纳入2044例患者。
  • 控制基于COPD稳定性和影响评估,第1-12周低影响且稳定者定义为控制,随访52周观察急性加重。

主要发现

  • 2044例患者中多数为非控制(80%),常因高影响。
  • 随访期间控制组中重度急性加重率显著更低(率比0.56,95%CI 0.48-0.65,p<0.0001)。
  • 控制组首次中重度急性加重时间显著延迟。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The concept of chronic obstructive pulmonary disease (COPD) control has been proposed to guide treatment decisions in COPD. In this study, we aimed to validate the prospective value of this concept in the SPARK study population. Control was assessed based on COPD stability and impact. Patients with low impact and stability during weeks 1-12 were classified as controlled, and exacerbations were measured during a 52-week follow-up. Of the 2044 patients included a majority were non-controlled (80%), frequently due to high impact. During the follow-up, the rate of moderate/severe exacerbations was significantly lower in controlled patients (rate ratio, 0.56, 95% CI 0.48 to 0.65 p<0.0001) and time-to-first moderate/severe exacerbation was significantly delayed. This study demonstrated an association between control status and risk of exacerbations.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Barrecheguren M, Kostikas K, Mezzi K, et al. COPD clinical control as a predictor of future exacerbations: concept validation in the SPARK study population. Thorax. 2020. PMID: 32041741. doi:10.1136/thoraxjnl-2018-212752

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。